Recent advances in the clinical application of aromatase inhibitors

Area of Science:

• Oncology
• Pharmacology

Background:

• Aromatase inhibitors have significantly evolved over two decades.
• These agents effectively inhibit aromatase activity in postmenopausal women.

Purpose of the Study:

• To review the evolution and current applications of aromatase inhibitors in breast cancer treatment.
• To discuss their potential as first-line therapy and in adjuvant and prevention settings.

Main Methods:

• Review of clinical data and ongoing trials.
• Analysis of efficacy compared to existing treatments like tamoxifen.

Main Results:

• Aromatase inhibitors are well-tolerated and effective in advanced breast cancer.
• They are currently preferred as second-line treatment after tamoxifen.
• Emerging data suggest they may be more efficacious than tamoxifen.

Conclusions:

• Aromatase inhibitors represent a significant advancement in breast cancer therapy.
• They are poised to become a first-line treatment option.
• Further studies will define their role in adjuvant treatment and prevention.